Category Archives: Dividend Stocks

Dividend Investments: Brookfield Global Listed Infrastructure Income Fund Offers Elevated Return Potential

Dividend Investments: Brookfield Global Listed Infrastructure Income Fund Offers Elevated Return Potential

Stock markets continue to trade near all-time highs, as both the S&P 500 and NASDAQ have posted recent records in their underlying valuations.  For investors, this can complicate the task of identifying inexpensive asset opportunities. But one sector that should be considered by value-oriented investors is in closed-end funds, which often trade at attractive discounts relative to net asset value.  Additionally, closed-end funds tend to offer excellent income opportunities for investors seeking reliable dividend payouts.

Dividend stock strategies work well in low-interest rate environments, so when investors are able to combine closed-end fund opportunities with strong income payers it becomes possible to identify the most ideal profitability scenarios in the financial markets.  The Brookfield Global Listed Infrastructure Income Fund Inc. (NYSE:INF) offers one such opportunity, with its annualized dividend payout of $0.98 per share (which is paid monthly).  This equates to a 7.95% distribution yield, which is far above the 1.76% dividend yield that is currently generated by the S&P 500.  

Stock Chart

The Fund has rallied over the last six months.  The Fund’s current largest 10 holdings are an indicator of the overall positioning and asset allocation.

Stock Holdings

Looking more deeply into the Fund, we can see that as of June 30, 2018, 99% of its managed assets were in publicly-traded equity securities of infrastructure companies.  As of July 31, 2018, the Fund has $202.81 million in assets under management (AUM). Recent rallies in share prices have been built on prior earnings progress from these companies, with broader valuations moving steadily higher since the beginning of 2016. In addition, market concerns regarding interest rate increases and inflation have somewhat subsided.

Market Outlook: Trade Tariffs and Monetary Policy

Most of the market has experienced some level of volatility and turmoil as the impact of political upheavals and heightened tariff discussions has made its influence felt.  We are still seeing escalating trade tensions between US, China, and the Eurozone – and this has had a ripple effect on stock exchanges around the world. Moreover, these bearish moves can be attributed to the panic felt by investors relating to potential interest rate increases at the Federal Reserve.

This activity generated many of the declines experienced in stocks such as INF during the February-March period in 2018, and the lower valuation generated by the selling pressure seems to have created a strong buying opportunity for yield-seeking, value-oriented investors.

Deeper NAV Discounts and Higher Returns

On a YTD basis, INF is trading lower by -4%, and this creates added discounts for investors relative to net asset value (NAV).

Closed-end Funds

Given the current trends in the market, INF is trading at a discount to NAV of 14.43%, and this suggests further upside potential in share prices.

Stable Distribution

The Fund is likely to continue attracting the attention of income investors due to its stable distribution payouts.  INF offers broad exposure to a global universe of equity securities of publicly-traded infrastructure companies. The Fund yields 7.95% at current price levels ($0.98 per share on an annualized basis). This creates interesting opportunities for value investors given the current low-interest rate environment and the Fund’s recent share prices.  

The potential for stable income and a diversification in a real asset class, such as infrastructure, helps INF stand out amongst its peers.  As a monthly distribution payer, the stock continues on its positive trend and broader sentiment seems to be falling in line with expectations. All combined, the outlook looks stable and investors could consider INF as a closed-end fund which may capitalize on its four core advantages: portfolio diversification, potential for capital appreciation, and its stable yields for income-seeking, value-oriented investors.

Bank Stocks: Wells Fargo Races Record Sanctions of $1 Billion

Wells Fargo Bank (NYSE:WFC) is making financial news headlines once again, as the government is ready to crack-down on the industry giant.  The stock value plunged on the news, and we are now trading near the lows from September 17, 2017:

Wells Fargo Bank Stock Prices
Wells Fargo Bank Stock Prices

Wells Fargo earnings reports have been positive, however, and the stock could now be a buy at the lows.  The stock comes with a dividend yield of 2.99%:

Wells Fargo Earnings & Revenues
Wells Fargo Earnings & Revenues

Wells Fargo (WFC) stock trading, technical analysis:

Citigroup: Stock Undeterred by a Hefty Tax Charge of $22 Billion

Citigroup: Stock Undeterred by a Hefty Tax Charge of $22 Billion

As a global banking leader for more than 20 years, Citigroup, Inc. (NYSE: C) posted a net income (on an operating basis) of $15.8bn in 2017 with an EPS of $1.28, 12% higher from 2016. This was the first time since the financial crisis of 2008 where earnings are more than their expectations.

The stock rallied to an all-time 10 year high of $80 on January 26, 2018. Total revenues in 2017 were up by 2%. Citi took a one time charge of $22bn (including $3bn in the repatriation of foreign funds) due to the Republican tax reform policy.

Citi stock is a favorite for shareholders and prospective investors as it has a steady EPS growth and is the cheapest of all banking stocks in the market. It is by far the largest of the top 10 banks in terms of EPS growth and P/E (according to Bloomberg Consensus). In terms of valuation, its stock is trading at a 22% discount and has a growing yield in its Corporate and Treasury bonds.

Source: Google Finance

With a good performance in 2017, it is now noticeable that Citi has come out the volatile period of revenue growth. Even after getting hit by a $22bn tax charge, Citigroup stock rose by 1%, as it delivered good performance excluding the charge. The new tax rate will give a boost to its profits.

Along with this, Citigroup CEO has reiterated on its promise of returning at least $60bn to investors in the next few years through buyback and dividends.

Citigroup Dividends: An Interesting Tale

Citigroup Dividend History
Citigroup Dividend History

On January 18, 2018, Citigroup doubled its dividend of $0.16 to $0.32 after receiving Fed approval for its $15.6bn share buyback program. This is the largest ever share repurchase announced by Citi since its 2005 buyback of $15bn. In June 2016, Citigroup had boosted its dividends to $0.16 from $0.05 – a total three-fold rise.

Prior to the financial depression in 2008-09, Citigroup was known for paying high dividends to the tune of $5.4 per share. During the crisis, it slashed its dividend down to $0.1 in February 2009 and did not pay any till June 2011. Post this, it kept its payout at a minuscule $0.01 till 2015 when it finally raised it to $0.05. Its current dividend yield is 1.88% and shareholders can expect an upward momentum in his regard.

Where Does Citi Stand with other Top Banks?

Source: NASDAQ

Comparing Citigroup with Bank of America, both have performed well in terms of their stock rise in 2017. Citigroup has increased 15% while Bank of America has grown by 26%. Citi’s forward earnings multiple is less than 10 while BAC is at 11%. Both banks provide a decent dividend yield of more than 1.5%, with Citi’s slightly higher at 1.87%. This makes Citigroup a better buy.

The impending trade war due to Trump’s policy also had an impact on Citigroup shares due to its geographic exposures (it has banking licenses in more than 100 countries). Hence, its stock growth was down last year compared to JPMorgan Chase (NYSE: JPM) and Bank of America (NYSE: BAC).

Intel Corporation: Stock Set to Rally as it Outperforms all Expectations

Amidst a lackluster stock market, Intel Corporation (NASDAQ: INTC) has been displaying strength enough to attract prospective investors. As of March 25, 2018, the Intel stock is trading 40% up year-to-date with reports of strong chip sales and improvement in the buying ratings by analytical firms.

In Q4 2017, Intel posted its operating income of $5.9bn, the highest ever in over two years. Its non-GAAP EPS was $1.08, which was 36.7% higher than the year-ago quarter. Due to the Republican tax reform, the company incurred a one-time expense of $5.4bn and posted a GAAP loss of 15 cents per share. Revenue for Q4 was $17.2bn (up by 8%) and for the full year was $62.8bn (up by 9%). It generated a cash flow of $22bn and returned $9bn to its shareholders by increasing its dividend by 10% on an annual basis.

How has the stock been performing?

Source: Google Finance

Intel stock has been rallying since the beginning of 2017 with a YTD growth of 44% (as on March 26). The market for computers has been slowing down, however, it has not much impacted Intel as the company is also growing in cloud data centers. The revenue for data centers grew by 21% in Q4 2017.

At the beginning of 2018, the stock dropped by 15% due to security threats and Intel processor bugs (found in chips) which left millions prone to a cyber attack. It led stock prices down to $42. However, its strong quarter Q4 results led the stock up by 15% to $52 in March 2018.

The stock for Intel has been growing after every quarter earnings release leading to a total stock gain in the past few months. Even though the computer market is on a slowdown in the recent years, the laptop market has grown substantially. The growth in the Smart phones industry also helped Intel as mobile devices are also dependent on data centers, and Intel is foraying in this market at a break neck pace. Analysts at Citi Research gave a ‘buy’ rating to the INTC stock expecting the firm to post strong profits in 2018.

Is Intel a healthy Dividend stock?

Source: NASDAQ

On March 15, 2018, Intel declared a dividend of $0.30 per share payable on June 1, 2018. The stock has a dividend yield of 2.35% which is greater than S&P 500 yield of 1.78%. In the past five years, Intel’s quarterly dividend rate has grown by 33%. It started paying dividends in 1993 but has not cut the dividend even during the dot-com bubble and the financial crisis. Shareholders have a greater advantage with Intel stock as the dividend hike is accompanied by stock price rise too.

Intel has a cash flow of $22bn and it paid a dividend of $5.1bn in 2017. This gives a payout ratio of 23.1% and leaves room for more dividend hikes in the future. With growing revenues and earnings, shareholders can be sure that the upward momentum will support the stock price rally and discreet investors can lock in capital gains.

Where does Intel Corp stand in the Top 10 stocks of the Dow Jones U.S. Technology Index (DJUSTC)?

Time to add Johnson & Johnson to your Portfolio as Sales Projected to Grow despite Headwinds

Johnson & Johnson (NYSE: JNJ), the global healthcare behemoth, posted Q4 2017 revenue of $20.2bn (an increase of 11.5%) and 2017 full-year earnings of $76.5bn (an increase of 6.3%) on January 23, 2018. Diluted loss per share was $3.99 (adjusted diluted EPS was $1.74 which was an increase of 10.1% compared to Q4 2016); while diluted EPS for 2017 full-year was $0.47 (adjusted diluted EPS was $7.36 which was an increase of 8.5%). The decrease was primarily due to the provisional charge of $13.6bn which was incurred due to the Republican tax reform. Free cash flow in 2017 was $17.8bn.

Source: Yahoo Finance

Exceeding the expectations set at the beginning of 2017, Johnson & Johnson also gave a total shareholder return of 24% with its Pharmaceutical business and Medical Device business showing great strengths. During 2017, it completed around 60 acquisitions and invested $10.5bn in R&D and $35bn in Mergers & Acquisitions. It also executed four divestitures as a part of its business fortification strategy.

Investment Outlook

Source: Google Finance

As the above chart shows, the J&J stock rallied to all-time highs of $147 in January 2018 before falling down 13% to around $127 in March 2018. It went to its highs during 2017 due to its product launches, positive clinical data, and strong Q3 2017 results. However, it declined by 13% in February 2018 due to the following reasons:

  • Q4 2017 results showed negative earnings due to the tax reform act
  • Sales decline in some of its drugs, baby care division, and specialty surgery
  • Talcum powder lawsuits since last year

As per the latest survey by Reuters, J&J stock has received a ‘buy’ or ‘strong buy’ rating from 52% of its analysts and a ‘hold’ rating from 35% of them.

However, looking toward 2018, Johnson & Johnson stock can be seen as a good investment for prospective shareholders due to the following reasons:

  1. With $10.5bn investment in Research & Development, J&J would also be tapping on the developing markets across the world.
  2. J&J’s forward price to earnings ratio is 18.5, lesser than the S&P 500 stock ratio, which makes it a good quality buy.
  3. With a presence in over 60 countries and a massive healthcare division, J&J is uniquely positioned to gain from economies of scale.

Dividend Outlook

As a Dividend Aristocrat, J&J has raised its dividend for consecutive 55 years and now has a yield of 2.5%. The dividend payout ratio stands at around 60%. In 2017, it spent $8.9bn in dividends – i.e. 50% of its free cash flow of $17.8bn. It paid its latest dividend of $0.84 on March 13, 2018. The 5% annual dividend increase for 2017 is low compared to the last eight years (last two annual increases were 6.7% in 2016 and 7.1% in 2015).

Even though J&J is using its cash flow to improve shareholder value, it is also being prudent with the way it manages its finances. Looking at the string of mergers and acquisitions conducted over the past few years, it seems that it would be offsetting these costs by balancing its dividend payout. This could be a reason for a decrease in annual dividend growth. However, all in all, its robust dividend payout despite the future challenges makes it a reliable stock in a prudent investor’s portfolio.

How Does JNJ Stock Compare with the Top Healthcare stocks in the Dow Jones U.S. Health Care Index (DJUSHC)?

Pfizer, Inc: As Earnings Improve, Pharmaceutical Giant’s Stock Shows a Positive Move

Since its inception in 1849, Pfizer, Inc. (NYSE: PFE) has introduced game-changing medicines in the market. In the past few years, the pharmaceutical giant has garnered confidence amongst shareholders and prospective investors by delivering a string of robust medicines which have contributed to its annual revenue. In Q4 2017, Pfizer’s Eliquis raked in $170m in revenue which was 46% higher than the year-ago figure, while Chantix-Champix contributed $271m in revenue which was 28% higher than the year-ago figure.

Pfizer had a satisfactory result in 2017 when it posted gains of 2% (y-o-y) in its revenue for Q4 2017 ($13.7bn) and Year-end 2017 ($52.5bn). Its diluted Q4 EPS of 62 cents beat Wall Street estimates of 56 cents per share. Compared to Q4 2016, Pfizer’s Innovative Health unit, which contributes 60% of the revenue, grew by 6% in Q4 2017 ($8.2bn); while Essential Health segment, which contributes the remaining 40%, declined by 7% in Q4 2017 ($5.5bn). Its overall revenue was negatively impacted by $2bn as it lost marketing exclusivity rights for some of its drugs like Enbrel, Pristiq, Viagra, Lyrica, and Vfend.

Source: Yahoo Finance

With the passage of the new tax reform act, Pfizer expects a $15bn tax bill over eight years (effective tax rate of 17%) and plans to invest approximately $5.6bn in capital projects, employee bonuses, and pension plans. Considering that it also has a strong portfolio of robust growth drugs, shareholders can remain bullish on Pfizer stock.

Source: Google Finance

Pfizer’s stock has experienced ups and downs during the past decade due to the loss of patent exclusivity of some of its top-selling drugs. In 2012, the sales dropped by 10% when it lost the patent battle for Lipitor, the cholesterol fighter drug. This also led to underperformance in terms of market share, revenue and net income growth. However, in recent years the company has benefitted from its targeted acquisitions, namely,

  • Acquisition of the development and commercialization rights of the EU drug Zavicefta™, Merrem™/Meronem™ and Zinforo™ from AstraZeneca in December 2016 for $1,045m
  • Acquisition of Medivation in September 2016 for $14.3bn
  • Acquisition of Anacor in June 2016 for $4.9bn
  • Acquisition of Hospira in September 2015 for $16.1bn

In 2017, the stock grew roughly by 17% due to gains in its robust drug pipeline. If the 2018 guidance is followed through, we can safely predict stocks to reach $40 by the third quarter of 2018.

Why should you choose to stay with Pfizer stock?

Pfizer’s dividend is the primary reason. Its current dividend yield of 3.7% is above the industry’s average of 3.2% and the S&P’s 2.0%. In its recent announcement, Pfizer increased the dividend by 6% (from $0.32 to $0.34 paid on March 1, 2018) which marks the 317th quarterly dividend paid by the company. In addition to this, it has increased it in the past nine consecutive years.

For fiscal 2017, it reported free cash flows of $14.25 billion. $7.66 billion was paid as dividends and $5bn as share buybacks which means that Pfizer at present has a free cash flow dividend payout ratio of around 53%. The broad pipeline of products under its umbrella and its strong dividend payment are reasons for investors to consider Pfizer as a reliable stock.

Procter & Gamble: Poised to Race Ahead as Brand Divestitures and Cost Productivity Measures Pays Off

Procter & Gamble (NYSE: PG) stock had slid 9.92% in February 2018 after its Q2 2018 earnings release on January 23, 2018. A tantalizing problem for this Household and Consumer products giant was its performance in terms of market share. For blades and razors, the share was down to 65% from 70% in 2014 while grooming products dropped by 0.7%.

As revealed in its 2017 fiscal year-end results, the overall market share was declining across each of its core product categories. With regards the competitive edge, P&G is not immune to the intense headwinds in the market which has brought stagnancy to its top line growth in the recent years. Its market share was also impacted due to the niche operators in the household sector. However, the situation is now improving as can be seen from its 2% rise in organic sales.

Source: Google Finance

The Q2 2018 results beat Wall Street estimates as it posted revenue of $17.40bn against the expected $17.39bn and a core EPS of $1.19 (including $0.05 benefit from the tax reform) against the expected $1.14. Net sales for the quarter were up by 3% against the year-ago figure while the gross margin slid by 60 basis points. The Republican tax reform brought in $135m in benefits costing a net charge of $628m. Cash flow from operating activities was $7.4bn.

Across the Household & Personal Care sector, P&G has an attractive dividend yield of 3.44% and a 5-year growth rate of 4.77%. It has been paying a dividend for the past 127 years and has increased the dividend for 61 consecutive years. The current yield of P&G is higher than the average yield of the top 15 Personal products stocks which is at 1.93%. In Q2 2018, it repurchased $1.8bn shares and spent the same value in dividends, thus resulting in a total of $3.6bn returned to shareholders.

The dividend would increase in the coming years too as P&G has been adopting a robust cost-saving plan coupled with its re-focus on core brands post its brand divestitures since 2014 (the number of brands was reduced to 65 from 170). This uninterrupted distribution of dividend has partially offset the recent drop in the stock prices.

P&G Annual Dividends (Source: NASDAQ)

Why can investors be hopeful for P&G?

Prospective investors can be prudent to invest in P&G due to its core operating profit margin of 22%. Since the company has scaled down on its brands in the last five years, it has been able to focus on higher returns; and with competitive pricing, it has been able to improve its profit margin. Now, with the appointment of Nelson Peltz (effective March 1, 2018) to its Board of Directors after a long proxy fight, investors are hopeful for a greater impact.

Comparing it with its close competitor Unilever, P&G has a better Dividend yield and has a higher payout ratio. Unilever’s annualized dividend fell in 2015, while P&G has seen a sustained increase, thus making it a better stock in a prudent investor’s portfolio.

In order to fund its sales and continue its pace of growth, productivity improvements are essential. Its supply chain financing program has generated over $4bn in cash in the past four years. The management has saved $10bn in the past four years and has projected to save the same amount in the next four years- all in all- leading to sustained growth. The stock will see a sure turnaround if it continues this initiative.

Energy Stocks: Exxon Mobil Could Rally on Higher Oil Prices

Oil prices have started to move higher and there is a better economic climate for Exxon Mobile Corp. (NYSE:XOM) to start posting strong gains into the next few quarters.  In addition to this, the stock has an excellent dividend yield of 3.5%.

Stock Price Chart Exxon Mobile Corp
Stock Price Chart Exxon Mobile Corp

Analyst stock recommendations:

Stock Analyst Recommendations
Stock Analyst Recommendations

Stock Price Target:

Stock Price Target
Stock Price Target
Stock Price Chart XOM
Stock Price Chart XOM

 

Dividend Stocks: Prospect Capital Trading Near Lows

Dividend Stocks: Prospect Capital Trading Near Lows

The Federal Reserve has set low interest rates for the US economy.  This makes dividend stocks especially attractive, and one of the most popular companies in this category is Prospect Capital Corp. (NASDAQ:PSEC).  Those with long positions in PSEC capture dividend yields of 10.5%, which is massive compared to most of the traded stocks in the market.

Stock Price Chart Prospect Capital (PSEC)
Stock Price Chart Prospect Capital (PSEC)

In this chart, Prospect Capital has posted negative earnings performances over the last three years:

Stock Market Earnings
Stock Market Earnings

Stock Analyst Recommendations:

Stock Analyst Recommendations
Stock Analyst Recommendations

The stock is trading at a 25% discount to net asset value (NAV):

Closed End Funds NAV Discount
Closed-End Funds NAV Discount

Stock Price Chart: PSEC Technical Analysis

Stock Price Chart: PSEC Technical Analysis
Stock Price Chart: PSEC Technical Analysis

AT&T: The Real Risk For Stock Investors

AT&T: The Real Risk For Stock Investors

  • Valuations in AT&T are now trading within striking distance of the 2015 lows.
  • Heightened competition in mobile and diminishing demand for traditional cable services have only been exacerbated by the building concerns over the viability of potential deals in acquiring Time Warner.
  • We believe the real risk here is that investors are so heavily positioned for a bullish outcome that any negative surprises could generate massive downside volatility in T before year-end.

The stock market rallies of 2017 have failed to make their presence felt in the valuation of AT&T (T), which is dealing with a disruptive confluence of negative events that has only fueled the stock’s downside volatility.  Heightened competition in mobile and diminishing demand for traditional cable services have only been exacerbated by the building concerns over the viability of potential deals in acquiring Time Warner (TWX).  

Real questions remain with respect to whether or not these agreements will reach a favorable conclusion.  But it continues to look as though the general consensus is positioning for the merger to proceed in its original form.  Are there too many passengers on one side of the boat?  Perhaps.  And this is the real risk for valuations in AT&T near-term.  If you are already long the stock (as we are) this is not enough of a reason to completely abandon ship, as there is still scope for an acceptable outcome for shareholders.  But, at the same time, we do not recommend loading up on T at current levels and investors will need to prepare for extended volatility going forward.

On a year-to-date basis, AT&T is trading lower by almost -20% in a broader market where the SPDR S&P 500 Trust ETF is showing gains of nearly +15.5% for the same period.  Volatility in TWX has been even more extreme of late, and the headlines over the weekend have focused on comments from President Donald Trump suggesting that he has not attempted to block the Time Warner deal unless CNN is sold to a separate media entity.  

Speculation here has run rampant over the last few weeks, as there is still a strong belief that Trump has a vendetta against CNN and that he is interested in blocking any potential deals that could benefit the company.  But, in our view, these discussions largely miss important parts of the equation.  We could still see the Department of Justice take these talks in an entirely different direction, namely a requirement to divest DirectTV rather than CNN.  

AT&T Deal with Time Warner

Most of the arguments siding with a likely approval of the Time Warner deal cite historical precedents in the Comcast (CMCSA) acquisition of NBC Universal.  But the reality is that these two arrangements not as similar as they might seem.  

As it was originally structured, the AT&T-Time Warner deal would have far more potential in terms of the ways a combined company could limit competitive influences within the industry.  CEO Randall Stephenson has gone to great lengths to explain that there is no interest in selling CNN, and it would not be surprising at this stage to see extended litigation to keep the finalized asset base intact.  

For investors, this suggests more volatility and since T is typically thought of as a conservative stock position it is still not entirely clear how the market will react if more downside moves are seen.  None of this even touches the discussion of how an approved deal would impact AT&T’s debt load (which would surpass $180 billion if the deal passed in its current form).  This would almost certainly lead to discussions on the way T’s dividend could be impacted — but that is a conversation that will have to be reserved for a later date once more information becomes available.

AT&T Chart Analysis

The market freefall in AT&T that occurred after hitting resistance near 43 has created a double-top in the region that will likely generate significant headwinds for the stock options trading outlook on a long-term basis.  All hope is not lost, however, because we are still in the midst of an ascending triangle formation that is bullish in nature as indicator readings are attempting to bounce out of oversold territory.  

This should help to stall further losses and we are now coming into additional support through the 200-period exponential moving average on the monthly charts.  Share prices in T have pivoted around this reading for the last several years, and so this will be a critical line in the sand to monitor for positioning ideas in the weeks and months ahead.  

Overall, there are arguments that can be made on both sides but the balance of the evidence still supports the bulls for the time being.  We will remain long T and collect on the 5.7% dividend yield until we see a breakdown in the aforementioned price support zones.